(Louis) Sonata, No. 5, Op. 80 (E-File)
by American Printing House for the Blind
Est. $10–$60, see price history
Typical price range, not a vendor quote. Confirm it with the vendor before buying.
What it is
Summary
AI-generated from vendor-published content · November 1, 2026
This is a braille music score file, Sonata No. 5, Op. 80, delivered as an electronic file (E-File) instead of a printed volume. It comes from the Louis database, a collection of braille and accessible materials from the American Printing House (APH). A braille music reader can use it with refreshable braille or a braille embosser. It gives a blind musician a score they can read by touch. The file is only the score, so you will also need a way to read or emboss the braille. It is eligible for Federal Quota funds, which can help schools pay for it.
Getting it
Try before you buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to get it
This is the vendor WhatCanHelp tracks for this product — it may also be available from other retailers or a local supplier, and prices vary.
How to fund this
These are common places to ask about paying for equipment like this. Each one decides its own eligibility and what it covers, so start by asking them.
Details
Quick Facts Catalog facts · auto-generated
- Addresses
- Platform
- Age range
- Complexity
- Ready to use
- Price
- Est. $10–$60
- Funding
- AT Act lending
- Out of pocket
- School district
What setup looks like
- Out of the box
Download the file after purchase and open it on a braille display or send it to a braille embosser.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site (opens in a new tab); last checked November 1, 2026.
Classification & description AI-generated from vendor-published content on November 1, 2026 · confidence: medium. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.